Cardiovascular Ultrasound System Market, by Test Type is segmented into Transthoracic Echocardiogram, Transesophageal Echocardiogram, Stress Echocardiogram, Other Echocardiograms (Fetal and Intracardiac Echocardiograms).
The “stress echocardiogram” segment is expected to account for the largest share of the market in 2016. This is due to the major advantage of the stress echocardiogram. The “stress echocardiogram” segment is expected to account for the largest share of the market in 2016. This is due to the major advantage of the stress echocardiogram that it can provide data of the cardiac muscle and valves before and after the stress of the heart, Muscle.
Ultrasound is increasingly being used outside the echo lab for point-of-care cardiac assessments in the office setting. Most of these systems are smaller, less expensive ultrasound systems used to triage a patient to determine the need for more detailed imaging exams.
Smaller, lighter, portable ultrasound units are finding utility for remote telecardiology programs in rural areas. The echoes can be recorded at remote clinics and sent via secure websites to a central hospital to be read by an echocardiographer.
Cardiovascular Ultrasound System Market by Technology is segmented into 2D, 3D & 4D, Doppler Imaging.The 2D technology is estimated to account for the largest share of the market in 2016; whereas the 3D & 4D technology segment is estimated to grow at the highest CAGR during the forecast period.
The use of 3D echo will likely see the most demand in procedures such as transcatheter ventricular septal defect (VSD) closures, left atrial appendage (LAA) closure, and MitraClip mitral valve repairs. While 2D echo remains the standard, there is increasing adoption of 3D/4D echo systems. These newer systems can allow better visualization, such as viewing the entire left ventricle, which is proven to be more accurate for quantification and measurements. The use of “3D echo” also offers surgical views that often aid procedural planning or interventional navigation.
Cardiovascular Ultrasound System Market by Device Display is segmented into Color Display, Black & White (B/W) Display. Cardiovascular Ultrasound System Market by End User is segmented into Hospitals/Cardiology Centers, Ambulatory/Home Care, Other End Users (Research Institutes, Medical Device and Pharmaceutical Companies).
The “hospitals segment” is expected to account for the largest share of the market in 2016. The “home care & ambulatory” segment is estimated to register the highest CAGR during the forecast period due to increase in the usage of echocardiographs at the patient's house itself. Cardiovascular Ultrasound System Market by Region is segmented into North America (U.S., Canada), Europe, Asia Pacific (India, China, Japan, Australia, New Zealand, Rest of the Asia-Pacific (RoAPAC)), Rest of the World (RoW).
Europe is expected to account for the largest share of the market in 2016. Factors such as growing product commercialization, expansion in clinical applications of high intensity focused ultrasound (HIFU) coupled with their early commercialization in Europe, and growing emphasis on non-invasive procedures by patients and physicians are driving the market growth in this region.
The Asia Pacific region is estimated to be the fastest-growing region in the market during the forecast period as it is an emerging market and provides growth opportunities such as healthcare spending, increase in research and innovation, and medical tourism. The Key players include GE Healthcare, Philips healthcare, Siemens Healthcare, Hitachi Medical Corporation, and Toshiba Medical Systems Corporation.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."